MiR-9-5p Inhibits Glioblastoma Cells Proliferation Through Directly Targeting FOXP2 (Forkhead Box P2)

• Published in: Frontiers in oncology Vol. 9; p. 1176
• Main Authors: Zhang, Hongbo, Li, Yuntao, Tan, Yinqiu, Liu, Qi, Jiang, Shuting, Liu, Dongyuan, Chen, Qianxue, Zhang, Shizhong
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 19.11.2019
• Subjects: FOXP2; glioblastoma; glioma; miR-9-5p; Oncology; proliferation; glioma; glioblastoma; proliferation; miR-9-5p; FOXP2
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2019.01176

Glioblastoma (GBM) is the most malignant tumor in the central nervous system and the treatment is still unsatisfactory because the mechanism of the disease remains unclear. The abnormal expression of miRNAs and its target proteins play a crucial role in the development of glioblastoma. In this study, we demonstrated that high expression of miR-9-5p and low expression of forkhead box P2 (FOXP2) were related with better outcome in patients with GBM, and down regulated FOXP2 expression was able to inhibit glioma cells proliferation by cell cycle arrest. Furthermore, we found that FOXP2 was the target protein of miR-9-5p in luciferase assay. The results of this study suggest a novel regulatory mechanism that miR-9-5p can inhibit glioma cells proliferation by downregulating FOXP2.